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Abstract
Background: Patient-reported outcomes measures in clinical trials ensure that evaluations of effectiveness focus on
outcomes that are important to patients. In relapsing-remitting conditions, such as eczema, repeated measurements
may allow a more accurate reflection of disease burden and treatment effect than less frequent measurements.
We asked parents/carers of children with eczema taking part in a trial of bath emollients to complete weekly
questionnaires for 16 weeks.
Methods: The objective of this study was to determine the acceptability and practicality of collecting weekly
measures of eczema severity online for 16 weeks in children aged 1 to 11 years as part of the BATHE study.
BATHE randomised patients to bath emollients plus standard eczema care or standard eczema care only. The
primary outcome was eczema severity, measured by the seven-item Patient-Oriented Eczema Measure (POEM)
repeated weekly for 16 weeks. Acceptability was explored through qualitative interviews with 10 participants.
Interviews were audio-recorded, transcribed and analysed thematically. Practicality was assessed by exploring the
completeness of the data and keeping a log of any problems.
Results: Four hundred and eighty-two participants were recruited to the trial and 429 opted to complete measures
online (89.0%). Data were collected online for 83% of time points over the 16-week period and there was no
association between socio-demographic characteristics and data completeness. Two hundred and six (48%)
completed their weekly data every week for 16 weeks and 341 (79%) completed it at least 80% of the time. The
mean number of weeks completed was 13.3 out of 16 (SD 4.2).
Interviewees said that they understood the rationale behind weekly collection and some welcomed this as it
helped them realise how their child’s eczema changed weekly. Whilst some interviewees spoke of weekly
questionnaires as onerous, others said that they found them quick and easy. Reminders were welcomed.
Parents/carers seemed happy to receive telephone reminders and it was sometimes useful for eliciting problems
relating to obtaining trial medication or password problems for online data collection.
(Continued on next page)
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Conclusions: Amongst this population, high levels of data completeness suggests that weekly completion of the
online questionnaire appears to be acceptable and feasible over a 16-week period.
Trial registration: ISRCTN84102309. Registered on 9 December 2013.
Keywords: Feasibility, Repeated measures, Trial methodology, Eczema, Atopic dermatitis, POEM, PROMs
Background
Repeated measures are frequently used in clinical trials,
rather than a single endpoint, in order to allow re-
searchers to explore how treatment or the trajectory of a
condition changes over time [1]. Repeated measures also
allow for increased power due to the reduced
intra-participant variability, which results in smaller
sample size requirements [1, 2]. Whilst regular measure-
ments may help to give a more accurate impression of
changing disease states, this must be balanced against
the feasibility of doing so within a trial context and the
burden it places upon participants and research staff to
ensure that these measures are completed.
Eczema is a common condition in childhood and can
have a significant impact on quality of life for both chil-
dren and parents due to itching and disturbed sleep [3].
In order for interventions to improve the quality of life
in a way that is relevant to children and parents, it is im-
portant that the outcome measures used in studies cap-
ture their experiences of eczema and any perceived
benefits of treatments Patient-reported outcome mea-
sures (PROMS) are reported directly by participants and
are being used increasingly as primary outcomes in clin-
ical trials in order to assess the overall patient experi-
ence or perception of benefit to participants [4].
Capturing the experiences of people with eczema is
complicated by the relapsing and remitting nature of the
condition. Therefore, gathering information regularly
over time is essential for understanding disease burden
[5], and to accurately assess the impact of interventions.
The BATHE trial aimed to assess the clinical and cost
effectiveness of bath emollients for eczema [6]. The pri-
mary outcome was the Patient Orientated Eczema Meas-
ure (POEM) measured weekly for 16 weeks. POEM is
the patient-reported outcome measure recommended by
NICE [7] and the international Harmonizing Outcome
Measures for Eczema initiative (http://www.homeforec-
zema.org/) for measuring eczema symptoms [8].
Although there are good reasons for collecting POEM
scores on a weekly basis from participants, prior to the
start of this trial there was no evidence as to whether it
would be acceptable or practical to do so. The study
team had experience of two prior studies which had
gathered data from participants on a daily basis. The
Softened Water Eczema Trial (SWET) had gathered
POEM daily data via paper diaries [9]. The data were
very complete with 94% of all data points complete at
16 weeks [10]. However, with paper diaries there is a risk
that participants may complete the measures at a later
date, backfilling the diary in order to return complete
data to the research team but increasing the risk of re-
call bias [11]. An observational study of flare triggers
also recorded eczema on a daily basis but using elec-
tronic diaries [12]. The diary could not be completed
after midnight on any given day, thereby eliminating the
risk of backfilling the diary, but the data were much less
complete, with only 60% of the data complete at
16 weeks [10].
The BATHE trial aimed to reduce the burden by col-
lecting the POEM scores weekly via an online platform.
This paper reports on the acceptability and practicality
of weekly data collection from participants in the con-
text of an eczema trial.
Methods
The BATHE study
The BATHE trial was a pragmatic, unmasked,
two-armed randomised controlled trial in general prac-
tices in England and Wales. Children aged 12 months to
11 years who met the UK Diagnostic Criteria for Eczema
[13], and who had mild to moderate eczema according
to the Nottingham Eczema Severity Score [14], were
randomised to either standard care or bath emollients
plus standard care. Participants were recruited from 96
practices in Wales, South of England, West of England
and Wales. Further details regarding the trial, including
full inclusion and exclusion criteria, can be found in the
published protocol [6] and published study results [15].
The primary outcome was the Patient Orientated Ec-
zema Measure (POEM) [16] completed weekly for
16 weeks. POEM is a patient-reported outcome based
on symptoms experienced over the previous week, which
can be completed by the child or their parent / carer.
POEM includes seven questions about eczema symp-
toms over the previous week that are summed to give a
score from 0 (eczema is clear or causing no impact) to
28 (very severe eczema). POEM is recommended by
NICE [17] and the international HOME initiative (Har-
monising Outcome Measures in Eczema) and is the only
patient-reported outcome that demonstrated sufficient
validity and repeatability in a systematic review of out-
come measures for eczema [18, 19]. Our primary
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outcome measure was based on repeated measures of
POEM data collected weekly over 16 weeks because this
reflected the impact of this relapsing and remitting
chronic condition better than comparing outcomes at a
single follow-up time point. In addition to collecting the
POEM each week, we also asked a weekly question
about adverse events. Parents were encouraged to
complete measures online and offered the option to
complete on paper only if they stated that they felt on-
line completion would be difficult.
Following the baseline appointment there were no
other face-to-face study visits, so efforts were made from
the outset to ensure that participants remained engaged
with the trial. These included small gifts (a bath duck
branded with the study logo, post-it notes and a bendy
eraser) given to each child at the start of the study.
Communication was encouraged by setting up a study
website, posting out birthday cards for the children and
Christmas cards for the families, as well as quarterly
newsletters. There were also incentives to encourage
continued participation including a ‘thank you’ card and
£10 voucher sent to parents before the 16-week ques-
tionnaire was due, and all participants were eligible for
inclusion in a prize draw for a tablet computer at the
end of the study.
Sample size
The sample size for BATHE was calculated for repeated
measures analysis of covariance (ANCOVA) in weekly
POEM scores over 16 weeks. With alpha 0.05 and beta 0.1,
we aimed to detect a difference of 2 points in the POEM
over the 16-week period (SD 7.0) based on data from the
SWET trial [9]. This gave a sample size of 338, rising to
423 with a 20% allowance for loss to follow-up. Early data
suggested that approximately 80% of participants in both
groups were adherent to treatment allocation. As we were
keen to report a secondary per-protocol analysis in addition
to a primary intention-to-treat analysis, we revised our
sample size to reflect this with approval from the funder,
sponsor and Trial Steering Committee. Assuming that 80%
of participants adhere to treatment allocation, we required
an additional 68 participants to retain 90% power for the
per-protocol analysis. This gave an increased recruitment
target of 491 participants.
The primary analysis for the trial used a mixed model
(for repeated measures), allowing participants to contrib-
ute data for all the time points for which they have com-
pleted a weekly questionnaire. For this study, we have
used all available data.
Data collection
Participants received a unique ‘log in’ and entered their
data online into a validated database. Parents/carers
were notified that the weekly questionnaire was available
to complete by email and by text/SMS on the day that it
fell due. A reminder was sent 2 days later if the POEM
had not been completed. The online questionnaires
remained available for completion for a further 5 days,
when they were replaced by the following week’s ques-
tionnaire. There was no facility to complete the online
POEM questionnaire retrospectively once the 7-day
period had elapsed.
Parents/carers had contact with the same member of
staff for the duration of the study so far as possible.
Questionnaire completion was monitored by the trial
team and efforts were made to contact participants by
telephone if their completion rate fell below 80%. Par-
ticular efforts were made to speak to those who failed to
complete the first week’s POEM, as this would suggest
difficulties with the log-in system. Particular efforts were
also made to speak to parents/carers who had not com-
pleted the 16-week questionnaire.
Although the online portal was designed to be
accessed via a desktop computer or tablet, we suspected
that many parents would access the website via their
mobile phone. Data on the user agent and referrer were
automatically captured by the online platform, enabling
us to describe the type of device from which parents/
carers logged in to record the weekly data.
Quantitative analysis
The proportion of parents/carers who opted for online
completion and the completeness of the data, both in
terms of the number of weeks, on average, for which
they completed measures and the overall number of data
points collected from the study population have been
analysed descriptively and graphically. Associations be-
tween key participant characteristics and data complete-
ness were explored using chi-squared tests with a 5%
significance level.
Qualitative interviews
All parents of affected children who were assigned to
the Southampton trial centre (across three geographical
counties in the South of England) within the first
10 weeks of the trial were contacted to offer an inter-
view primarily by email, then by telephone if there was
no email response. An answerphone message was left
for the first occasion of an unanswered call, but no fur-
ther messages were left in the further calls that were
made (up to three per participant).
Semi-structured interviews were undertaken with 10
parents following an interview guide. Interviews were
carried out either face-to-face or, where the participant
preferred, by telephone. Interviews were audio-recorded,
professionally transcribed and transcripts were checked
against recordings. An inductive thematic analysis [20]
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was conducted to explore people’s experiences and views
of participating in the BATHE study.
Two authors (CS and MS) read the transcripts several
times and produced a coding framework, which devel-
oped iteratively as further transcripts became available.
Disconfirming cases were sought. Data saturation was
not achieved for all themes (e.g. motivation for partici-
pating in trials) but was achieved for our main theme ex-
ploring experiences of weekly data collection.
Pseudonyms have been applied in reporting the data and
for all quotes used below.
Results
Four hundred and eighty-two participants were recruited
from 96 general practice (GP) surgeries across three cen-
tres: Southampton, Bristol and Cardiff (South of Eng-
land, West of England and Wales). Only four
participants withdrew from the trial. Invitation letters
were posted from the participating GP surgeries to
12,523 children who had received a prescription for ec-
zema treatment within the previous 12 months. The
mean response rate overall was 11.55% (3.9–25%): posi-
tive eligible replies, after exclusions, averaged 3.86% (0–
14.3%) of invitations sent.
Practicality
Online weekly questionnaire completion was chosen by
429 (89.6%) participants. Of the remaining 50 partici-
pants, 27 (5.6%) requested paper and 23 (4.8%) were
switched from online to paper format after discussion
with the study team. Reasons for this primarily related
to technical issues: some parents became discouraged
after having problems logging in to the online database
or issues with connectivity. Where parents/carers con-
tacted the study team about this issue, they were often
able to log in once their password had been re-set, indi-
cating that they had forgotten their log-in details (which
were case-sensitive). However, it is unclear how many
gave up at this point without reporting the problem.
Log-in problems were occasionally compounded by a
failure to understand the automated nature of the sys-
tem and that they would be unable to go back to
complete past POEMs. Some parents reported difficul-
ties getting access to the family computer and there were
also individual issues such as changing service providers,
poor Internet connections, as well as long family holi-
days. Paper case report forms (CRFs) consisted of four
POEMs printed in A5 booklets. They were posted out
monthly, with a covering letter and pre-paid envelope.
The characteristics of the participants are set out in
Table 1. Although the numbers completing on paper
were small compared to those completing online, there
was no evidence of any difference in characteristics by
method of completion.
As shown in Fig. 1, the online weekly POEM was well
completed. If all 429 participants completed their data
as expected, we would have collected 6864 data points.
We collected 5680 data points, making the data 83%
complete. Only four participants were lost to follow-up,
due to withdrawal from the study. The primary analysis
of the trial was, therefore, able to include data from 99%
of the participants and was over 80% complete. Given
Table 1 Participant characteristics by method of completion
Online (n = 429) Paper (n = 27) Switched to paper [23]
Child age in years (SD) 6.6 (2.8) 6.3 (2.6) 6.2 (2.6)
Child gender
Male 206 (48.1%) 16 (59.2%) 15 (68.2%)
Female 222 (51.9%) 11 (40.7%) 7 (31.8%)
Ethnicity
White 364 (86.1%) 23 (85.2%) 16 (72.7%)
Asian 16 (3.8%) 1 (3.7%) 1 (4.6%)
Chinese 8 (1.9%) 1 (3.7%) 2 (9.1%)
Black 11 (2.6%) 0 0
Mixed 21 (5.0%) 2 (7.4%) 3 (13.6%)
Other 3 (0.7%) 0 0
How cost of living affects household
Find it a strain 11 (2.6%) 1 (3.7%) 2 (9.1%)
Have to be careful 164 (39.0%) 13 (48.1%) 8 (36.4%)
Able to manage 168 (39.9%) 11 (40.7%) 11 (50.0%)
Quite comfortable 68 (16.2%) 2 (7.4%) 1 (4.6%)
Not answered 10 (2.4%) 0 0
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that the sample size calculation allowed for 20% of par-
ticipants to be lost to follow-up, this was well within
what was required in order to provide adequate data for
the analysis of the primary outcome.
There was a slight increase in the percentage com-
pleted at week 16, despite the final POEM being embed-
ded within a longer questionnaire. Parents were sent a
‘thank you’ card and a £10 voucher just before the
16-week questionnaire was due, and a reminder letter
and paper copy of the questionnaire were posted out if
the online questionnaire had not been completed within
7 days (n = 80).
Of the 429 parents/carers completing their data online,
206 (48%) completed their weekly data every week for
16 weeks. Three hundred and forty-one (79%) completed
their weekly data at least 80% of the time. The median
number of weeks completed was 15 out of 16 (inter--
quartile range (IQR) 13, 16). There were no differences
between the two trial arms with respect to completeness
with a median of 15 [12, 16] for the group allocated to
Fig. 1 Percentage of participants completing the Patient-Oriented Eczema Measure (POEM) each week
Table 2 Data completeness by participant characteristics
Data complete at least 80% of the time
(n = 341)
Data not complete at least 80% of the
time (n = 88)
Chi-squared test statistics (p
value)
Study arm 2.86 (p = 0.104)
Usual care 145 (43.2%) 46 (52.9%)
Bath emollient 191 (56.6%) 41 (47.1%)
Child age 2.86 (p = 0.091)
Under 5 years 112 (32.8%) 37 (42.5%)
5 years and over 229 (67.2%) 50 (57.5%)
Child gender 0.07 (p = 0.787)
Male 163 (47.8%) 43 (49.4%)
Female 178 (52.2%) 44 (50.6%)
Ethnicity 3.46 (p = 0.063)
White 297 (87.6%) 67 (79.8%)
Non-white 42 (12.4%) 17 (20.2%)
How cost of living affects
household
3.06 (p = 0.382)
Find it a strain 8 (2.4%) 3 (3.8%)
Have to be careful 139 (41.9%) 25 (31.7%)
Able to manage 131 (39.5%) 37 (46.8%)
Quite comfortable 54 (16.3%) 14 (17.7%)
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the usual-care arm and a median of 15 (IQR 13, 16) for
those allocated to the bath-emollient arm. Of those who
completed online, 93 (49%) in the usual-care arm and
109 (47%) in the bath-emollient arm, completed their
weekly measures for all 16 weeks.
There was no association between study arm, sex of
child, age of child, ethnicity or financial circumstances
and the completeness of the data. (see Table 2). Data
from the group who completed on paper were less
complete with only 42% of weekly data points com-
pleted. Figure 2 shows the distribution of responses over
the 16-week study period.
The webpages where parents/carers completed the
POEM were designed to be completed online on a com-
puter or laptop. They could be viewed and completed on
a mobile phone but were not designed with this in mind.
However, of the 9784 times that parents logged in to the
website, 5963 (61%) were from mobile devices. A further
912 (9%) were from tablets whilst 2909 (30%) were from
computers or laptops.
Feedback from trial staff suggested that the collection
of weekly data was not problematic. On average, they re-
ported needing to make a total of 6–10 telephone con-
tacts per week to remind parents to complete the POEM
online. Overall, approximately 25% of the sample re-
quired following up by telephone at some point in order
to ensure that their measures were completed. Over the
course of the study, 274 (57%) had no direct contact
with the trial team (beyond automated messages, news-
letters, etc.). Thirty-four had contact re issues with pre-
scriptions/medications/reactions, and 71 had contact re
technical issues. The technical problems were the most
burdensome to deal with.
Trial staff felt that the efforts that had been made to
engage participants with the study were helpful in ensur-
ing that the weekly measures were completed. Trial staff
also believed that parents having a single point of
contact within the trial team throughout the study also
encouraged engagement.
Acceptability
Nineteen parents/carers were contacted to request a
qualitative interview, of whom 10 were interviewed:
none refused but seven did not respond to repeated tele-
phone calls to try to arrange an interview. A further two
interviews were arranged, but were cancelled by the par-
ticipant. Five interviews were carried out face-to-face
(four in the interviewees’ homes, and one in a public set-
ting) and five interviews were carried out by telephone.
All those interviewed were mothers, aged 32–49 years
with a child aged between 2 and 8 years old.
Almost all interviewees said that they found the ques-
tionnaires quick and easy. A few mentioned that they
did not find questionnaires difficult but were pleased
that they would become less frequent as the trial pro-
gressed (the POEM was asked monthly between week 16
and week 52).
Annabel gives a very typical answer:
Interviewer: ‘What do you think of the weekly
questionnaires?’
Annabel: ‘Fine…to the point – quick – no problem…’.
Most interviewees said that they understood why the
questionnaires were weekly as their child’s eczema was
variable and some actually liked completing the ques-
tionnaires as it made them appreciate this variation
more. One person reported initially thinking that weekly
questionnaires were too much, as she did not think that
her child’s eczema severity would alter. During the inter-
view, however, Louisa reports that she was able to notice
differences on a weekly basis:
Fig. 2 Data completeness over the 16-week period
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Louisa: ‘ When I heard that it was going to be weekly,
I thought “well, surely things aren’t going to change
that much”, but actually, when it comes to it – my
little one’s skin, it really does change that much…So I
think weekly is a good interval’.
One interviewee reported finding difficulty with the
weekly questionnaires, as she was forgetting to complete
them:
Interviewer: ‘…What have you thought of the weekly
questionnaires?’
Annie: ‘I’ve had trouble doing it every week: yes, I
look at them and then I – put my phone down and
then I forget all about it…It’s remembering…’.
In addition to their feelings about weekly question-
naires for the first 16 weeks, parents/carers were asked
about their feelings around the year-long nature of the
trial. (Participants continued to receive monthly ques-
tionnaires after 16 weeks until 52 weeks). A number of
interviewees reported seasonal variation in their child’s
eczema, and thought that the year-long follow-up would
allow this to be reflected in the data:
Linda: ‘You need a year – I would have thought…Our
(eczema) changes in every season, depending on
whether we’ve got the heating on…’.
Interviewer: ‘So the fact it is... ’.
Linda: ‘It is a year, it’s brilliant’.
Discussion
We found that it is both feasible and acceptable to col-
lect repeated measures of eczema severity online over a
16-week period in the context of a clinical trial. Parents/
carers and trial staff gave positive feedback about their
experience of completing the measures online. Some
participants did have difficulties, and 23 had to be
switched to paper completion. However, almost 90% of
participants completed their data online, the data were
83% complete and only four participants were lost to
follow-up, allowing 99% of participants to contribute at
least one data point to the primary analysis. There was
no association between participant socio-demographic
characteristics and data completeness.
BATHE was a pragmatic trial and it was not possible
to blind participants to their group allocation. This led
to concerns that there might have been differential attri-
tion, with participants randomised to usual care feeling
less engaged and failing to complete measures, which
may lead to biased results [21]. However, we did not find
evidence of this. The median number of weekly mea-
sures completed was 15 out of 16 weeks in both arms,
suggesting that strategies to keep participants in both
groups engaged with the study were successful.
There was evidence that although data completion
started high, with over 90% responding in the first week,
the response rate as shown in Fig. 1 declined over time,
falling to just below 80% in weeks 11–14 of the study.
The trial design meant that resources were targeted at
the final follow-up point, when a number of other mea-
sures were due and this increased the completion rate at
week 16 to 93%. Targetting resources at key time points,
particularly during longer follow-up periods, may help
to keep participants engaged with the study and increase
the completenss of the data.
Although rates of data completion were high, the trial’s
data collection procedures may not have been optimised
for the methods that participants used. Whilst the data
collection was designed primariliy to be completed on-
line via a computer or tablet, 61% of log ins were from
mobile devices. According to the Office for National Sta-
tistics, Internet access ‘on the go’ using mobile devices
has increased steadily over the last 5 years with 73% of
adults accessing the Internet from a mobile phone in
2017 [22]. Future studies should acknowledge this trend
and ensure that the data collection procedure is opti-
mised for viewing and completion on a mobile device.
Whilst using an online data collection approach did
yield relatively complete data in this study, there were
challenges. Difficulties with logging in were one of the
main reasons that participants contacted trial staff.
Log-in problems, including lost IDs and passwords, may
have resulted in some participants being put off taking
part without further contact with the trial team. In fu-
ture, other secure log-in options, such as an app or an
encrypted link for each participant, might help to avoid
this potential difficulty.
Strengths and limitations
This study only evaluated the feasibility and acceptability
of completing the weekly POEM online. As noted above,
digital technologies and mobile phones are becoming in-
creasingly pervasive in everyday life, and, in future,
people may find it more convenient to use apps or SMS
to provide data [23] Participants did receive text mes-
sage reminders but could not complete their POEM
questionnaire via text. Although we believe that it is very
likely that the feasibility of completing the POEM weekly
online would translate into these other media, this
would have to be evaluated further [24].
Qualitative interviews with a larger number of partici-
pants, including participants who completed paper ques-
tionnaires, or purposively sampling participants with low
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completion rates, may have generated further useful in-
sights and is planned for future trials.
Findings in context of existing research
The collection of repeated measures data is known to
suffer from problems with attrition [25] as is data col-
lected as part of studies administered online [26]. The
level of completeness achieved with the online weekly
POEM of 83% was comparable to that observed in three
other recent eczema trials. The COMET feasibility study
asked participants to complete a daily diary for 12 weeks
by paper or using an electronic app. Due to problems
with the online app, only 11/196 participants completed
measures using the app but POEM data were complete
for between 70 and 75% of all participants (paper and
online) over the 12-week period [27]. The CREAM trial
measured POEM data at 4 weeks and 3 months and
achieved a response rate of 86.7 and 65.5%, respectively
[28]. The CLOTHES trial collected POEM data weekly
for 24 weeks and 85% of participants completed 12 or
more of the weekly questionnaires [29].
Weekly data collection has been used in clinical trials
of other medical conditions. A trial of weekly
self-monitoring in asthma concluded that it improved
asthma control and was feasible, with 80% completing
the weekly data collection online as instructed during
the first 3 months [30]. Self-monitoring is frequently in-
cluded as part of behavioural weight-loss interventions
[31] and several studies have included weekly diaries to
collect physical activity and nutrition information. These
studies have found weekly diaries to be reasonably
complete – 62.7% in Carel et al.’s 14-week randomised
controlled trial (RCT) [32] and 83% in the first 6 months
of Wing et al.’s 18-month RCT [33]. Weekly testing has
also been trialled for the self-management of oral
anti-coagulant therapy and showed that weekly
self-management is feasible and provided some protec-
tion from complications [34]. This study, therefore, fits
within existing literature suggesting that weekly data col-
lection can be feasible and acceptable in a clinical trial
setting.
Implications for future research
It is possible that frequent assessment allows partici-
pants to provide more accurate recall and thus reduces
bias [35]. However, it is also possible that repeatedly ask-
ing participants about eczema symptoms changes their
perception and hence their responses, causing a re-
sponse shift [36]. It may alter adherence to study medi-
cations and co-treatment and introduce a performance
bias if weekly assessment of eczema status is not part of
normal routine care. It is, therefore, important to evalu-
ate whether, in addition to being feasible and acceptable,
the collection of weekly POEM data is actually useful
when compared to using measures taken at less frequent
time points. The HOME group is continuing to explore
the best way to capture long-term control of eczema
[37] and the data gathered as part of the BATHE trial
will be evaluated alongside data from other eczema trials
to help to inform decisions about how frequently to ask
participants to complete the POEM in future studies
and over what time period.
Conclusion
In this population, weekly completion of the online
questionnaire appeared to be acceptable and feasible
over a 16-week period. Email, text and telephone re-
minders seemed helpful to most participants.
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